文献速递肺外科

建立胸外科亚专科项目可改善肺癌手术结局

Establishing a Dedicated General Thoracic Surgery Subspecialty Program Improves Lung Cancer Outcomes.
PubMed 文献 · Ann Thorac Surg · 2016-12-08

该研究基于医院癌症登记数据库,回顾性分析2002至2013年279例肺癌肺叶切除术患者,比较2008年前后建立胸外科亚专科项目(聚焦微创手术与胸部肿瘤)的结局。结果显示,项目建立后VATS比例提高、住院时间缩短、淋巴结采样增加,且总生存率显著改善(HR 0.41,95%CI 0.25-0.68)。

要点

  • 亚专科项目建立后VATS肺叶切除比例从9.5%升至53.9%,住院时间中位数从7.0天降至3.5天。
  • 淋巴结采样总数(9.0 vs 6.3)和站数(4.2 vs 2.8)均增加。
  • 总生存率显著改善(HR 0.41,95%CI 0.25-0.68),各分期亚组均获益。

核心结论

  • 建立由胸外科专科医生主导、聚焦微创手术与胸部肿瘤的亚专科项目可显著改善肺癌肺叶切除术的短期和长期结局。

研究设计与样本

  • 回顾性队列研究,基于医院癌症登记数据库,纳入2002至2013年279例肺癌肺叶切除术患者,按手术日期以2008年1月为界分为项目建立前和建立后两组。

主要发现

  • 项目建立后VATS手术比例显著增加(53.9% vs 9.5%)。
  • 项目建立后住院时间中位数缩短(3.5天 vs 7.0天)。
  • 项目建立后每例患者平均采样淋巴结总数增加(9.0 vs 6.3),采样站数增加(4.2 vs 2.8)。
  • 项目建立后总生存率更优(HR 0.41,95%CI 0.25-0.68),按分期分层后生存获益仍显著(I期HR 0.46,II期HR 0.32,III-IV期合并HR 0.19)。

临床怎么用

  • 在心胸外科中建立聚焦微创手术和胸部肿瘤的亚专科项目,可提高VATS使用率、缩短住院时间、增加淋巴结采样并改善肺癌患者长期生存。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Various factors may influence outcomes after lobectomy for lung cancer. Postgraduate subspecialty training in general thoracic surgery with a focus on minimally invasive surgery (MIS) and thoracic oncology was completed by an established cardiothoracic surgeon on the hospital staff in July 2007, and principles emphasized in that training were incorporated into practice through formation of a subspecialty program. We hypothesized that establishing a dedicated general thoracic surgeon-lead subspecialty program, with focus on MIS and thoracic oncology, would improve short-term and long-term outcomes. METHODS: Patients entered into the hospital cancer registry have survival status updated annually through correspondence with patients, physicians, and searches of the Social Security Death Index and obituaries. The registry was queried for all patients undergoing lobectomy for lung cancer, 2002 to 2013, and divided into two groups for comparison, before and after, based on operation date relative to January 2008. Patients (n = 279) who had lobectomy for lung cancer were identified in the registry. Data included surgical approach (percent of video-assisted thoracoscopy [VATS]), pathologic stage, number of lymph nodes and stations sampled, hospital length of stay (LOS), and survival. χ2 statistics were used for proportions, t tests for continuous variables, and a nonparametric test for LOS. A Cox proportional hazard model was created, and survival curves were constructed using time between operation and death or last follow-up. RESULTS: Patients having lobectomy in the after group had substantially more VATS procedures (53.9% versus 9.5%), decreased LOS (median 3.5 versus 7.0 days), greater mean total lymph nodes (9.0 versus 6.3), and nodal stations (4.2 versus 2.8) sampled per patient. Thirty-day, 90-day, and 1-year survival were similar in both groups. Overall survival was better in the after group (hazard ratio [HR] 0.41, 95% confidence interval: 0.25 to 0.68), and this survival benefit remained statistically significant when comparing groups stratified by lung cancer stage (stage I: HR 0.46, stage II: HR 0.32, combined stage III to IV: HR 0.19). CONCLUSIONS: Establishing a dedicated general thoracic surgeon-lead subspecialty program, with focus on MIS and thoracic oncology, can substantially improve short-term outcomes with increased VATS utilization, decreased LOS, and increased lymph node sampling. Long-term survival was also significantly improved.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Magee MJ, Herbert MA, Tumey L, et al. Establishing a Dedicated General Thoracic Surgery Subspecialty Program Improves Lung Cancer Outcomes. Ann Thorac Surg. 2016. PMID: 27938908. doi:10.1016/j.athoracsur.2016.09.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。